Alpha-Lipoic Acid (Ala) for Nerve Function

Research suggests that alpha-lipoic acid may support nerve function, particularly in the context of diabetic peripheral neuropathy, with multiple studies reporting improvements in nerve conduction velocity, pain reduction, sensory perception, and autonomic function. The evidence base includes a 2014 review of randomized controlled trials and meta-analyses concluding ALA is effective and well-tolerated for diabetic neuropathy, a six-month human trial showing improved nerve function measures alongside other supplements, a separate six-month trial of ALA alone demonstrating improvements in sensory and autonomic nerve tests alongside reductions in endothelial dysfunction markers, and several animal studies illuminating potential mechanisms involving antioxidant pathways such as Nrf2 and AMPK signaling. Studies indicate that most findings point in a supportive direction, though important limitations apply across the body of evidence, including small sample sizes, the use of combination supplements that make it difficult to isolate ALA's specific contribution, and mixed results in at least one trial where overall group differences were not statistically significant. Taken together, the research is encouraging but not conclusive, and many of the human studies are small pilots or involved ALA as part of a multi-ingredient formula, meaning larger and more rigorously controlled trials are needed to fully establish the independent role of ALA in supporting nerve health.